BofA Finance LLC has announced a new offering of contingent income auto-callable securities, totaling approximately $10.8 million. This move is significant as it reflects the company's ongoing efforts to provide innovative financial products while navigating a competitive banking landscape.

The filing, dated October 27, 2026, reveals that the securities are designed to attract investors looking for potentially higher returns linked to the performance of Eli Lilly and Company stock. This offering is part of BofA Finance's broader strategy to enhance its portfolio of structured investments.

Background

BofA Finance LLC, classified under the SIC code 6021 for National Commercial Banks, is a subsidiary of Bank of America Corporation. The company is incorporated in Delaware and operates primarily out of Charlotte, North Carolina. The recent filing is part of a series of filings made on the same date, indicating a robust activity in their financial offerings.

What the Filing Says

The pricing supplement outlines the terms of the securities, which are contingent income auto-callable with a memory coupon feature. The securities are due on October 26, 2029, and are fully guaranteed by Bank of America Corporation. The offering is structured to provide contingent quarterly coupons based on the performance of Eli Lilly's stock, with an initial threshold price set at 80% of the initial share price.

Impact

This new offering may attract a range of investors, particularly those interested in structured products with a higher risk-reward profile. The securities' performance is closely tied to the stock of Eli Lilly, which may influence investor sentiment and market dynamics within the national commercial banking sector. Additionally, this move may set a precedent for other banks to explore similar structured investment products.

What's Next

The filing does not specify what happens next, leaving investors and market observers to await further announcements or developments from BofA Finance LLC regarding this offering.